YbCl3 with successively 2KL or 2KL′ and then >2Li in thf yields crystalline [Yb{L(μ-Li(thf)}2] 1 or [Yb{L′(μ-Li(thf)}2].thf 2, characterised by X-ray, multinuclear NMR spectral and VT magnetic susceptibility data; 1 and 2 are best formulated as Yb(II) complexes having dianionic L2− or L′2− ligands, L or L′ = {N(SiMe3)C(R)}2CH (R = Ph or C6H4Ph-4).
No takes yet. Share an insight, caveat, or question.
Avent et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: